Merck & Co., Inc.
MRK
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vacciā¦ read more
Healthcare
Drug ManufacturersāGeneral
47 years
USD
Exclusive to Premium users
Price
per share adjusted in USD$86.28
Price+0.58%
$0.50
1Y
Price
Market Cap
$215.500b
Large
Price/Earnings 3y Avg5y Avg
11.4x
Premium
Premium
Financials Overview
Key metrics over the past few years+39.0%
EBITDA Margin+33.5%
Net Profit Margin+14.6%
Free Cash Flow MarginRevenue
$64.235b
+0.1%
1y CAGR+2.8%
3y CAGR+7.5%
5y CAGREarnings
$19.034b
+11.2%
1y CAGR+1501.1%
3y CAGR+1128.6%
5y CAGREPS
$7.57
+12.3%
1y CAGR+1543.0%
3y CAGR+1160.0%
5y CAGRBook Value
$49.060b
$117.523b
Assets$68.463b
Liabilities$35.402b
DebtDebt to Assets
30.1%
1.3x
Debt to EBITDAFree Cash Flow
$14.722b
-18.6%
1y CAGR+13.8%
3y CAGR+23.4%
5y CAGRFinancial Reports
Earnings and other important metrics. Amounts in USD.No items found.
Press Releases
Statements and updates from the company